Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/ROQ stock hub

LON/ROQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/ROQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

n/a

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/ROQ

In the news

Latest news · LON/ROQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-18.2

P25 -54.2P50 2.1P75 13.7

ROIC-10.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/ROQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

132

Groups with data

Currency

GBP

Showing 132 of 132 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	7
Employees Change	-3%
Employees Change Percent	-30
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BSHRN331
Last refreshed	2026-05-10
Price	GBX 0.95
Price currency	GBX
Sector	Healthcare
Sic	6726
Symbol	lon/ROQ

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	GBX -882,451
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Profit Per Employee	GBX -126,064
ROA	-9.93
ROCE	-18.51
ROE	-18.23
ROIC	-10.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.88%
Cagr3y	-76%
Cagr5y	-59.3%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 5.7M
Cash	GBX 182,923
Current Assets	GBX 1.8M
Current Liabilities	GBX 627,210
Debt	GBX 383,650
Debt Equity	GBX 0.08
Debt FCF	GBX -0.59
Equity	GBX 4.8M
Interest Coverage	-17.4
Liabilities	GBX 909,121
Long Term Assets	GBX 3.9M
Long Term Liabilities	GBX 281,911
Net Cash	GBX -200,727
Net Debt Equity	GBX 0.04
Tangible Book Value	GBX 890,944
Tangible Book Value Per Share	GBX 0.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.8
Net Working Capital	GBX 1.3M
Quick ratio	0.34
Working Capital	GBX 1.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94.86%
200-day SMA	14.47
3Y total return	-98.62%
50-day SMA	9.08
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.88%
All Time High	136.3
All Time High Change	-99.3%
All Time High Date	2021-09-28
All Time Low	0.68
All Time Low Change	40.74%
All Time Low Date	2023-05-02
ATR	1.26
Beta	-0.56
Ch YTD	-92.4
High	1.06
High52	30
High52 Date	2025-11-28
High52ch	-96.83%
Low	0.95
Low52	0.95
Low52 Date	2026-04-01
Low52ch	0%
Ma50ch	-89.53%
Price vs 200-day SMA	-93.43%
RSI	46.22
RSI Monthly	37.76
RSI Weekly	41.5
Sharpe ratio	0.85x
Sortino ratio	5.97
Total Return	-4.18%
Tr YTD	-92.4
Tr1m	-90.69%
Tr1w	-88.48%
Tr3m	-92.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -932,135

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Qo Q	12.76%
Shares Yo Y	4.18%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -645,618
Average Volume	142,107.75x
Bv Per Share	0.3
CAPEX	GBX -56,865
Ch1m	-90.69
Ch1w	-88.48
Ch1y	-94.86
Ch3m	-92.96
Ch3y	-98.62
Ch5y	-98.88
Ch6m	-95
Change	-5%
Change From Open	-10.38
Close	1
Days Gap	6
Depreciation Amortization	5,404
Dollar Volume	481,837.2
Earnings Date	2026-04-27
EBIT	GBX -932,135
EBITDA	GBX -926,731
EPS	GBX -0.06
F Score	2
FCF	GBX -645,618
Financing CF	236,000
Fiscal Year End	December
Founded	2,020
Income Tax	GBX -161,371
Investing CF	-57,058
Is Primary Listing	0
Last Earnings Date	2025-12-29
Last Report Date	2025-06-30
Ma150	13.8
Ma150ch	-93.12%
Ma20	7.05
Ma20ch	-86.53%
Net CF	-412,739
Open	1.06
Position In Range	0
Ppne	42,046
Price Date	2026-03-26
Relative Volume	3.57x
Tr6m	-95%
Volume	507,197

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/ROQ pay a dividend?

Capital-return profile for this ticker.

Performance

LON/ROQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/ROQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.2%

Negative means the company is buying back shares.

Technical

LON/ROQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.2

Neutral momentum band

Price vs 200-day MA

-93.4%

50/200-day relationship not available

Beta (5Y)

-0.56

Less volatile than the market

Sharpe ratio

0.85

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/ROQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/ROQ stock rating?

lon/ROQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/ROQ analysis?

The full report lives at /stocks/lon/ROQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/ROQ?

The latest report frames lon/ROQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/ROQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.